Search research articles
Contact Us
Filters
Showing results (71-80 of 82) with videos related to
Page
of 9
Sort By:
Human Reproduction (Oxford, England)
|
March 5, 2004
Blocking of the placental immune-modulatory ferritin activates Th1 type cytokines and affects placenta development, fetal growth and the pregnancy outcome
R Nahum, O Brenner, M A Zahalka, et al.
Cancer
|
July 1, 1984
Ferritin-bearing lymphocytes in the diagnosis of breast cancer
C Moroz, M Kan, C Chaimof, et al.
Cancer Letters
|
July 20, 1995
Alterations of cell surface antigens induced by placental isoform of ferritin in human carcinoma cell lines
J Sedlak, M Reinerova, L Hunakova, et al.
Breast Cancer Research and Treatment
|
January 1, 1996
Immunosuppression by breast cancer associated p43-effect of immunomodulators
H R Rosen, C Ausch, G Reiner, et al.
Breast Cancer Research and Treatment
|
January 1, 1992
Placental isoferritin associated p43 antigen correlates with features of high differentiation in breast cancer
H R Rosen, C Moroz, A Reiner, et al.
Cancer Letters
|
October 30, 1992
Expression of p43 in breast cancer tissue, correlation with prognostic parameters
H R Rosen, C Moroz, A Reiner, et al.
Cancer Letters
|
July 15, 1994
Downregulation of lymphocyte mitogenesis by breast cancer-associated p43
H R Rosen, C Ausch, G Reiner, et al.
Oncology
|
January 1, 1989
Radioimmunodetection of tumors with monoclonal antiplacental ferritin antibody: preliminary results
C Moroz, Z Lantsberg, O Sela, et al.
Prenatal Diagnosis
|
July 1, 1996
Placental isoferritin in pregnancies with small-for-gestational age fetuses
A C Rosen, E Hafner, L Auerbach, et al.
Cancer Letters
|
June 10, 1998
Activated lymphocytes from breast cancer patients express the characteristics of type 2 helper cells--a possible role for breast cancer-associated p43
H R Rosen, C Ausch, M Reinerova, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 82) with videos related to
Sort By:
Page
of 9
Human Reproduction (Oxford, England)
|
March 5, 2004
Blocking of the placental immune-modulatory ferritin activates Th1 type cytokines and affects placenta development, fetal growth and the pregnancy outcome
R Nahum, O Brenner, M A Zahalka, et al.
Cancer
|
July 1, 1984
Ferritin-bearing lymphocytes in the diagnosis of breast cancer
C Moroz, M Kan, C Chaimof, et al.
Cancer Letters
|
July 20, 1995
Alterations of cell surface antigens induced by placental isoform of ferritin in human carcinoma cell lines
J Sedlak, M Reinerova, L Hunakova, et al.
Breast Cancer Research and Treatment
|
January 1, 1996
Immunosuppression by breast cancer associated p43-effect of immunomodulators
H R Rosen, C Ausch, G Reiner, et al.
Breast Cancer Research and Treatment
|
January 1, 1992
Placental isoferritin associated p43 antigen correlates with features of high differentiation in breast cancer
H R Rosen, C Moroz, A Reiner, et al.
Cancer Letters
|
October 30, 1992
Expression of p43 in breast cancer tissue, correlation with prognostic parameters
H R Rosen, C Moroz, A Reiner, et al.
Cancer Letters
|
July 15, 1994
Downregulation of lymphocyte mitogenesis by breast cancer-associated p43
H R Rosen, C Ausch, G Reiner, et al.
Oncology
|
January 1, 1989
Radioimmunodetection of tumors with monoclonal antiplacental ferritin antibody: preliminary results
C Moroz, Z Lantsberg, O Sela, et al.
Prenatal Diagnosis
|
July 1, 1996
Placental isoferritin in pregnancies with small-for-gestational age fetuses
A C Rosen, E Hafner, L Auerbach, et al.
Cancer Letters
|
June 10, 1998
Activated lymphocytes from breast cancer patients express the characteristics of type 2 helper cells--a possible role for breast cancer-associated p43
H R Rosen, C Ausch, M Reinerova, et al.
Page
of 9